META ANALYSIS FOR THE EFFECTS OF SOY ISOFLAVONE INTERVENTION ON BONE DENSITY IN WOMEN

刘静,苏宜香,邓娟,吴江南,陈裕明
DOI: https://doi.org/10.3321/j.issn:0512-7955.2008.05.020
2008-01-01
Abstract:Objective To evaluate the effects of soy isoflavones on bone density (BMD) in women in randomized clinical trials by meta-analysis. Method We searched the databases the Medline, Pubmed, and CNKI from January 1990 to October 2007 using the keywords, phytoestrogen, isoflavone, soy, genistein in combination with bone. We only included the studies of randomized clinical trial, in which the data of BMDs at lumbar spine, total hip or femoral neck prior to and post isoflavone intervention or their relevant changes and their standard deviation or 95% CI in women were provided. Results Sixteen papers (1304 women, 91% postmenopausal) were included and a mean daily dose of 73 mg supplemental soy isoflavones resulted in weighted mean (%)(95%CI) difference in yearly BMD changes of 18.3 (2.0%,CI 6.0~30.6) and 3.3(0.40%,CI 0.5~6.1) mg/cm2 at the lumber spine and total hip, respectively. Subgroup analyses showed that the effects were more pronounced in those with the isoflavone dose ≥80 mg/d than those of 80mg/d, and in those with a shorter intervention duration (1year) than those with longer duration (≥1year). The pooled effects increased slightly when the studies were limited to postmenopausal women. Conclusion Isoflavone supplementation has a statistically beneficial effect on BMD changes at the lumber spine and total hip in women.
What problem does this paper attempt to address?